How Canadian apparel brand Arc’teryx’s bold campaign spiraled into a PR cautionary tale
Arc’teryx staged a bold marketing campaign featuring fireworks display in Tibet, drawing fierce social media backlash over its potential environmental damage.
China stays conspicuously quiet after Trump’s TikTok deal declaration
U.S. President Donald Trump says that he’s received Beijing’s nod on a deal that would see TikTok stay alive in the U.S.
Fintech Checkout.com’s valuation falls to $12 billion
The internal valuation of $12 billion represents a significant decline from the $40 billion assigned to Checkout.com in a 2022 funding round.
Oil giant BP quietly steps out of the takeover spotlight
Takeover speculation regarding British energy major BP appears to have dried up, with shares of the company up more than 32% since early April.
Barclays CEO double downs on U.K. despite bank tax risk
C.S. Venkatakrishnan warned that “milking the financial sector is not good, because it stifles investment.”
We’re in an AI ‘super cycle,’ top investor says — and it could last 20 years
The AI super cycle will “change the world in every aspect,” B Capital’s Raj Ganguly told CNBC’s “Beyond the Valley” podcast.
Asian pharma stocks fall after Trump slaps 100% levies on branded drugs
The 100% duties apply to “any branded or patented Pharmaceutical Product” except for companies that build manufacturing plants in the U.S., Trump said Friday.
Trump slaps 25% tariffs on heavy trucks imports, starting Oct. 1
The decision came as Trump took aim at a swath of imported goods with fresh tariffs, as part of the broader campaign to encourage domestic manufacturing.
NASA Marshall Space Flight Center director Joseph Pelfrey resigns
The director of NASA’s Marshall Space Flight Center in Huntsville, Alabama, announced his resignation on Thursday.
U.S. to impose 100% tariff on branded, patented drugs unless firms build plants locally, Trump says
The measure will not apply to companies building drug manufacturing plants in the U.S., Trump added.